Close

Teva Pharma (TEVA), Xenon Pharm (XENE) Announce TV-45070 4%, 8% Phase 2b Did Not Achieve Statistical Significance

July 1, 2015 8:04 AM EDT Send to a Friend
Teva Pharma (NYSE: TEVA) and Xenon Pharmaceuticals Inc. (Nasdaq: XENE) reported top line results from the double-blind, placebo-controlled Phase 2b ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login